维普期刊资源整合服务平台（V6.5）

39篇 您的检索式：作者名="STENLOF K"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Two year reduction in sleep apnea symptoms and associated diabetes incidence after weight loss in severe obesity显示文摘	Grunstein RR Stenlof K Hedner JA	2007	Sleep2007，30，6：	1
2	Efficacy and safety of canagliflozin monotherapy in subjects w ith type 2 diabetes mellitus inadequately controlled w ith diet and exercise显示文摘	Stenlof K Cefalu WT Kim KA	2013	Diabetes Obes M etab2013，15，4：	1
3	Two year reduction in sleep apnea symptoms and associated diabetes incidence after weight loss in severe obesity 显示文摘	Grunstein RR Stenlof K Hedner JA	2007	Sleep2007，30，6：	1
4	Impact of obstructive sleep apnea and sleepiness on metabolic (SOS) study显示文摘	Grunstein RR Stenlof K Hedner J	1995	Int Obesity1995，19，：	1
5	Efficacy and safety of canagliflozin monotherapy in subjects with type 2diabetes mellitus inadequately controlled with diet and exercise显示文摘	Stenlof K Cefalu WT Kim KA	2013	Diabetes Obes Metab2013，15，4：	1
6	Body weight and body composition change after treatment of hyperthyroidism 显示文摘	Lonn L Stenlof K Ottosson M	1998	J Clin Endocrinol Metab1998，83，12：	1
7	Body weight and body composition changes after treatment of hyperthyroidism显示文摘	LONN L STENLOF K OTTOSSON M	1998	Clin Endocrinol Metab1998，83，12：	1
8	Efficacy and safe- ty of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and ex- ercise 显示文摘	Stenlof K Cefalu WT Kim KA	2013	Diabetes Obes Metab2013，15，4：	1
9	Efficacy and safety ofcanagliflozin monotherapy in subjects with type 2 diabetes melli-tus inadequately controlled with diet and exercise 显示文摘	STENLOF K CEFALU WT KIM KA	2013	DiabetesObes Metab2013，15，4：	1
10	Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study显示文摘	Grunstein R R Stenlof K Hedner J		0，，06：	1
11	Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 di- abetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study 显示文摘	STENLOF K CEFALU WT KIM KA	2014	Curt Med Res Opin2014，30，2：	1
12	Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise显示文摘	Stenlof K Cefalu WT Kim KA	2013	Diabetes Obes Metab2013，15，4：	1
13	Two year reduction in sleep apnea symptoms and associated diabetes incidence after weight loss in severe obesity 显示文摘	Grunstein RR Stenlof K Hedner JA	2007	Sleep2007，30，：	1
14	Efficacy and safety of eanagliflozin treatment in older subjects with type 2 diabetes mellitus:a randomized trial 显示文摘	BODE B STENLOF K SULLIVAN D	1995	Hasp Pract1995，20，2：	1
15	Effects of growth hormone treatment on the leptin syslem and on energy expenditure in abdominally obese men显示文摘	Karlsson C Stenlof K Johannsson G	1998	Eur J Endocrinol1998，138，4：	1
16	Growth of pulsed electric field exposed Escherichia coli in relation to inactivation and environmental factors显示文摘	Aronsson K Borch E Stenlof B	2005	International Journal of Food Microbiology2005，93，1：	1
17	Efficacy and safety of canagliflozin treatment in older subjects with type 2 diabetes mellitus显示文摘	Bode B Stenlof K Sullivan D	2013	Hosp Pract2013，41，2：	1
18	Energy expenditure in obstructive sleep apnea: effects of treatment with continuous positive airway pressure 显示文摘	Stenlof K Grunstein R Hedner J	1996	Am J Physiol1996，271，6：	1
19	Efficacy and safety of canaglif lozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled显示文摘	Stenlof K Cefalu WT	2013	Diabetes Obes Metab2013，15，4：	1
20	Efficacy and safetyof canagliflozin monotherapy in subjects with type 2 diabetes mellitusin adequately controlled with diet and exercise显示文摘	STENLOF K CEFALU WT KIMK A	2013	Diabetes ObesMetab2013，15，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示